Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vaia Florou

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Journal of Gastrointestinal Oncology|January 10, 2024
Durable response to first-line PARP inhibition in <i>BRCA</i>-mutated metastatic cholangiocarcinoma: case reportJarrod T Smith, Shashank Sama, Vaia Florou, et al.
BMC Cancer|October 12, 2022
Treatment outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma: a real world studyLaura Miotke, Christopher Nevala-Plagemann, Jian Ying, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 24, 2021
Clinical Activity of Selitrectinib in a Patient With Mammary Analogue Secretory Carcinoma of the Parotid Gland With Secondary Resistance to EntrectinibVaia Florou, Christopher Nevala-Plagemann, Jonathan Whisenant, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2023
A Real-World Comparison of Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer in the United StatesChristopher Nevala-Plagemann, Shashank Sama, Jian Ying, et al.
JCO Precision Oncology|February 5, 2021
Treatment Rechallenge With Checkpoint Inhibition in Patients With Mismatch Repair-Deficient Pancreatic Cancer After Planned Treatment InterruptionVaia Florou, Christopher Nevala-Plagemann, Kristin E Barber, et al.
Critical Reviews in Oncology/Hematology|August 27, 2013
Models for mature T-cell lymphomas--a critical appraisal of experimental systems and their contribution to current T-cell tumorigenic conceptsKathrin Warner, Giuliano Crispatzu, Nabil Al-Ghaili, et al.
Cancer Medicine|February 10, 2025
A Review of Genomic Testing and SDH- Deficiency in Gastrointestinal Stromal Tumors: Getting to the GISTVaia Florou, Michelle F Jacobs, Ruth Casey, et al.
Breathe (Sheffield, England)|July 23, 2021
A 51-year-old man with chronic cough and left hilar prominenceIsmini Kourouni, Scott W Aesif, Stephen W Tamarkin, et al.
JAMA Network Open|January 8, 2025
KRAS Mutation Status and Treatment Outcomes in Patients With Metastatic Pancreatic AdenocarcinomaCarter Norton, Matthew Steven Shaw, Zachary Rubnitz, et al.
Journal for Immunotherapy of Cancer|August 10, 2019
Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institutionVaia Florou, Andrew E Rosenberg, Eric Wieder, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Journal of Gastrointestinal Oncology|January 10, 2024
Durable response to first-line PARP inhibition in <i>BRCA</i>-mutated metastatic cholangiocarcinoma: case reportJarrod T Smith, Shashank Sama, Vaia Florou, et al.
BMC Cancer|October 12, 2022
Treatment outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma: a real world studyLaura Miotke, Christopher Nevala-Plagemann, Jian Ying, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 24, 2021
Clinical Activity of Selitrectinib in a Patient With Mammary Analogue Secretory Carcinoma of the Parotid Gland With Secondary Resistance to EntrectinibVaia Florou, Christopher Nevala-Plagemann, Jonathan Whisenant, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2023
A Real-World Comparison of Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer in the United StatesChristopher Nevala-Plagemann, Shashank Sama, Jian Ying, et al.
JCO Precision Oncology|February 5, 2021
Treatment Rechallenge With Checkpoint Inhibition in Patients With Mismatch Repair-Deficient Pancreatic Cancer After Planned Treatment InterruptionVaia Florou, Christopher Nevala-Plagemann, Kristin E Barber, et al.
Critical Reviews in Oncology/Hematology|August 27, 2013
Models for mature T-cell lymphomas--a critical appraisal of experimental systems and their contribution to current T-cell tumorigenic conceptsKathrin Warner, Giuliano Crispatzu, Nabil Al-Ghaili, et al.
Cancer Medicine|February 10, 2025
A Review of Genomic Testing and SDH- Deficiency in Gastrointestinal Stromal Tumors: Getting to the GISTVaia Florou, Michelle F Jacobs, Ruth Casey, et al.
Breathe (Sheffield, England)|July 23, 2021
A 51-year-old man with chronic cough and left hilar prominenceIsmini Kourouni, Scott W Aesif, Stephen W Tamarkin, et al.
JAMA Network Open|January 8, 2025
KRAS Mutation Status and Treatment Outcomes in Patients With Metastatic Pancreatic AdenocarcinomaCarter Norton, Matthew Steven Shaw, Zachary Rubnitz, et al.
Journal for Immunotherapy of Cancer|August 10, 2019
Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institutionVaia Florou, Andrew E Rosenberg, Eric Wieder, et al.
Pageof 6